What is the official website of Voisin Consulting Life Sciences (VCLS) ?

The official website of Voisin Consulting Life Sciences (VCLS) is http://www.voisinconsulting.com.

What is Voisin Consulting Life Sciences (VCLS)'s cybersecurity risk score?

Voisin Consulting Life Sciences (VCLS) has an AI-generated cybersecurity risk score of 753 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Voisin Consulting Life Sciences (VCLS) experienced?

According to Rankiteo, Voisin Consulting Life Sciences (VCLS) currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Voisin Consulting Life Sciences (VCLS) been affected by any supply chain cyber incidents ?

According to Rankiteo, Voisin Consulting Life Sciences (VCLS) has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Voisin Consulting Life Sciences (VCLS) have SOC 2 Type 1 certification ?

According to Rankiteo, Voisin Consulting Life Sciences (VCLS) is not certified under SOC 2 Type 1.

Does Voisin Consulting Life Sciences (VCLS) have SOC 2 Type 2 certification ?

According to Rankiteo, Voisin Consulting Life Sciences (VCLS) does not hold a SOC 2 Type 2 certification.

Does Voisin Consulting Life Sciences (VCLS) comply with GDPR ?

According to Rankiteo, Voisin Consulting Life Sciences (VCLS) is not listed as GDPR compliant.

Does Voisin Consulting Life Sciences (VCLS) have PCI DSS certification ?

According to Rankiteo, Voisin Consulting Life Sciences (VCLS) does not currently maintain PCI DSS compliance.

Does Voisin Consulting Life Sciences (VCLS) comply with HIPAA ?

According to Rankiteo, Voisin Consulting Life Sciences (VCLS) is not compliant with HIPAA regulations.

Does Voisin Consulting Life Sciences (VCLS) have ISO 27001 certification ?

According to Rankiteo,Voisin Consulting Life Sciences (VCLS) is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Voisin Consulting Life Sciences (VCLS) operate in ?

Voisin Consulting Life Sciences (VCLS) operates primarily in the Biotechnology Research industry.

How many employees does Voisin Consulting Life Sciences (VCLS) have ?

Voisin Consulting Life Sciences (VCLS) employs approximately 222 people worldwide.

Does Voisin Consulting Life Sciences (VCLS) own any subsidiaries ?

Voisin Consulting Life Sciences (VCLS) presently has no subsidiaries across any sectors.

How many LinkedIn followers does Voisin Consulting Life Sciences (VCLS) have ?

Voisin Consulting Life Sciences (VCLS)'s official LinkedIn profile has approximately 34,375 followers.

What is the NAICS classification code for Voisin Consulting Life Sciences (VCLS) ?

Voisin Consulting Life Sciences (VCLS) is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).

Does Voisin Consulting Life Sciences (VCLS) have a Crunchbase profile ?

No, Voisin Consulting Life Sciences (VCLS) does not have a profile on Crunchbase.

Does Voisin Consulting Life Sciences (VCLS) have a LinkedIn profile ?

Yes, Voisin Consulting Life Sciences (VCLS) maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/voisin-consulting-life-sciences.

How many cybersecurity incidents has Voisin Consulting Life Sciences (VCLS) experienced ?

As of July 5, 2026, Rankiteo reports that Voisin Consulting Life Sciences (VCLS) has not experienced any cybersecurity incidents.

How many peer or competitor companies does Voisin Consulting Life Sciences (VCLS) have ?

Voisin Consulting Life Sciences (VCLS) has an estimated 4,714 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

VCLS

Boost Score +25 with badge (5 left)

753

/1000

Fair

778

/1000

Fair

Voisin Consulting Life Sciences (VCLS) Vendor Cyber Rating & Cyber Score

voisinconsulting.com

Add Your Compliance Badge

From discovery to product launch and lifecycle management At VCLS (Voisin Consulting Life Sciences), regulatory science guides Biotechnology, Pharmaceutical and Medtech manufacturers throughout product development and commercialization. Starting early in the process, from discovery to the patient, VCLS assists innovators in designing optimized product development plans and regulatory strategies, combining the health ecosystem with commercial success. With a presence in seven locations across three continents and over 200 employees, VCLS serves a broad range of healthtech developers and their investors. Together, we accompany global stakeholders to expedite HealthTech products from discovery to patient access and beyond by bridging

VCLS A.I CyberSecurity Scoring

Scoring History

VCLS

Voisin Consulting Life Sciences (VCLS) CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

VCLS Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for VCLS

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Voisin Consulting Life Sciences (VCLS) in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Voisin Consulting Life Sciences (VCLS) in 2026.

Incident Types VCLS vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Voisin Consulting Life Sciences (VCLS) in 2026.

Incident History - VCLS (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Voisin Consulting Life Sciences (VCLS) Subsidiaries

VCLS

Biotechnology Research

Website: http://www.voisinconsulting.com

Company Size: 222

WORMS SafetyInternational Trade and Development

Asia Quality FocusWholesale Import and Export

Challenge Optimum S.A.Business Consulting and Services

API - Asia Pacific Inspection LtdTransportation, Logistics, Supply Chain and Storage

International Aviation SafetyAviation and Aerospace Component Manufacturing

SgT GroupTextile Manufacturing

Loading…

Voisin Consulting Life Sciences (VCLS) Similar Companies

Thermo Fisher Scientific

thermofisher.com

About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Amgen

amgen.com

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen was named one of the “World’s Most Innovative Companies” by Fast Company and one of “America’s Best Large Employers” by Forbes. For more information, visit Amgen.com and follow us on X, LinkedIn, Instagram, TikTok, YouTube and Threads. 🔗 Community Guidelines: https://wwwext.amgen.com/community-guidelines 🔗Global Privacy Statement Directory: www.amgen.com/dp Special Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen. Such scams may come from various sources, including fake websites and/or unsolicited emails and seek to obtain personal data or payment from victims by offering jobs that do not exist. Please be advised that Amgen would never ask for payment to progress a job application. When in doubt, please check to see if the position in question is posted on this website before applying. Additionally, please report any suspicious recruiting activity to https://complaint.ic3.gov/ and thank you for your assistance.

bioMérieux

biomerieux.com

A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in vitro diagnostics and have contributed greatly to improving public health and making the world a healthier place. The solutions that our teams imagine, develop and manufacture are key to enable healthcare professionals and industry players to make confident decisions to improve patient outcome and ensure consumer safety.

Syneos Health

cb syneoshealth.com

Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.

Gilead Sciences

cb gilead.com

At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines

Agilent Technologies

cb agilent.com

Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio. Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories. Additionally, the unique expertise of Agilent’s CrossLab and technical teams provides valuable insight and support to our customers, helping them fully optimize their laboratories and resources to better focus on what's important: bringing great science to life. In fiscal 2022, Agilent Technologies generated revenue of (US) $6.85 billion.

Avantor

cb avantorsciences.com

Avantor® is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 300,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. More than 14,500 strong, our associates are passionate about our mission to set science in motion to create a better world. We share enthusiasm for innovation, excellence, and achievement. Whether we are collaborating with our customers to advance science or solve multifaceted problems, we help them reach their goals more efficiently and effectively. Visit our website to learn more about Avantor.

Eurofins

cb eurofins.com

Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing. Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.

CSL

cb csl.com

CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our businesses, CSL Behring, CSL Seqirus, and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000+ people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. See our community guidelines: https://bit.ly/3Bs17Ra

Loading…

NEWS

Voisin Consulting Life Sciences (VCLS) CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

January 26, 2026 08:00 AM

Oracle picked to handle drug safety for rare-drug trials

Voisin Consulting Life Sciences selected Oracle Argus to upgrade its global pharmacovigilance operations, aiming to enhance compliance,...

Read Article

January 26, 2026 08:00 AM

Oracle (ORCL) stock: Jumps as Argus Adoption Strengthens Life Sciences Growth Outlook

ORCL rises to $183.50 as VCLS adopts Argus, boosting pharmacovigilance and strengthening life sciences growth outlook worldwide.”

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-14683

SUMMARY

A vulnerability was detected in HdrHistogram up to 2.2.2. Affected by this issue is the function org.HdrHistogram.AbstractHistogram.decodeFromCompressedByteBuffer of the file src/main/java/org/HdrHistogram/AbstractHistogram.java. The manipulation of the argument lengthOfCompressedContents results in uncontrolled memory allocation. The attack needs to be approached locally. The exploit is now public and may be used. The project was informed of the problem early through an issue report but has not responded yet.

Published

Date2026-07-04

Updated

Date2026-07-04

RISK INFORMATION (Score: 3.3)

cvss2

Base Score: 1.7

Complexity: LOW

AV:L/AC:L/Au:S/C:N/I:N/A:P

cvss3

Base Score: 3.3

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:L

cvss4

Base Score: 1.9

Complexity: LOW

CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:N/VI:N/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

1.8

REFERENCES

CVE-2026-14660

SUMMARY

A vulnerability was found in code-projects Online Job Portal 1.0. The affected element is an unknown function of the file login.php. Performing a manipulation of the argument txtUser/txtPass results in sql injection. The attack may be initiated remotely. The exploit has been made public and could be used.

Published

Date2026-07-04

Updated

Date2026-07-04

RISK INFORMATION (Score: 7.3)

cvss2

Base Score: 7.5

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:P/A:P

cvss3

Base Score: 7.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 5.5

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

3.9

REFERENCES

CVE-2026-14659

SUMMARY

A vulnerability has been found in itsourcecode Hospital Management System 1.0. Impacted is an unknown function of the file /patientappointment.php. Such manipulation of the argument patiente leads to sql injection. The attack can be launched remotely. The exploit has been disclosed to the public and may be used.

Published

Date2026-07-04

Updated

Date2026-07-04

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

CVE-2026-14658

SUMMARY

A vulnerability was detected in code-projects Assessment Management 1.0. This vulnerability affects unknown code of the file /lecturer/marking-scheme.php. The manipulation of the argument smarksrange[] results in sql injection. It is possible to launch the attack remotely. The exploit is now public and may be used.

Published

Date2026-07-04

Updated

Date2026-07-04

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

CVE-2026-14657

SUMMARY

A flaw has been found in code-projects Assessment Management 1.0. This issue affects some unknown processing of the file /lecturer/marking-scheme.php of the component Database Query Handler. This manipulation of the argument squestions[] causes sql injection. The attack can be initiated remotely. The exploit has been published and may be used.

Published

Date2026-07-04

Updated

Date2026-07-04

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…